To verify that the KMT2B mutations observed in cfDNA at low VAFs were true positive mutations, targeted deep sequencing was performed in two giant cell tumor of bone (GCTB) specimens that did not have KMT2B c.7804A > G in the original tumors. Here, KMT2B is linked to giant cell tumor.